Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Farmers Insurance
Medtronic
Argus Health
Teva
Cantor Fitzgerald
Citi
QuintilesIMS
Deloitte

Generated: July 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020682

« Back to Dashboard

NDA 020682 describes GLYSET, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from one supplier. Additional details are available on the GLYSET profile page.

The generic ingredient in GLYSET is miglitol. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the miglitol profile page.
Summary for 020682
Tradename:GLYSET
Applicant:Pharmacia And Upjohn
Ingredient:miglitol
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Pharmacology for NDA: 020682
Mechanism of Actionalpha Glucosidase Inhibitors
Suppliers and Packaging for NDA: 020682
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLYSET miglitol TABLET;ORAL 020682 NDA Pharmacia and Upjohn Company LLC 0009-5012 N 0009-5012-01
GLYSET miglitol TABLET;ORAL 020682 NDA Pharmacia and Upjohn Company LLC 0009-5013 N 0009-5013-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Dec 18, 1996TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Dec 18, 1996TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Dec 18, 1996TE:ABRLD:Yes

Expired US Patents for NDA 020682

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-001 Dec 18, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-003 Dec 18, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-002 Dec 18, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
UBS
QuintilesIMS
US Department of Justice
Fish and Richardson
Accenture
Federal Trade Commission
Argus Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.